The WACC of Revance Therapeutics Inc (RVNC) is 9.1%.
| Range | Selected | |
| Cost of equity | 7.60% - 15.20% | 11.40% |
| Tax rate | 0.10% - 0.10% | 0.10% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 7.3% - 10.8% | 9.1% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.81 | 1.84 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.60% | 15.20% |
| Tax rate | 0.10% | 0.10% |
| Debt/Equity ratio | 1.14 | 1.14 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 7.3% | 10.8% |
| Selected WACC | 9.1% | |